APH insider sale notice: 30,000 shares via Morgan Stanley ($3.32M)
Rhea-AI Filing Summary
Amphenol Corporation (APH) Form 144 notifies the SEC of a proposed sale of 30,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $3,324,249.00. The filing states the shares were acquired and are to be sold on 08/18/2025 via exercise of options under a registered plan and paid for in cash. The issuer's total shares outstanding listed in the form are 1,220,921,111, and there were no reported sales in the past three months for this account. The filer represents there is no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Form 144 for option exercise sale; immaterial supply increase versus outstanding shares.
This filing discloses a single proposed sale of 30,000 shares (~0.0025% of outstanding shares) following an option exercise and immediate cash payment. Filings of this type are standard when insiders or affiliated persons sell shares under Rule 144 to comply with resale conditions. The sale is executed through a major broker and lists no recent prior sales, which suggests this transaction is isolated and procedural rather than signaling company-level developments.
TL;DR: Disclosure meets Rule 144 requirements; no governance red flags disclosed.
The notice includes required attestations about absence of undisclosed material information and indicates the securities were acquired by exercise of registered-plan options. There is no indication of coordinated or large-scale disposal, and the filing does not disclose any trading plan dates. From a governance perspective, the form appears compliant and does not raise material concerns in isolation.